Cargando…

Commentary: Accessibility of cancer drugs in Switzerland: Time from approval to pricing decision between 2009 and 2018

Detalles Bibliográficos
Autor principal:	Grischott, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531232/ https://www.ncbi.nlm.nih.gov/pubmed/33072689 http://dx.doi.org/10.3389/fpubh.2020.00517

Ejemplares similares

The Impact of COVID-19 on Mental Healthcare Utilization in Switzerland Was Strongest Among Young Females—Retrospective Study in 2018–2020
por: Rachamin, Yael, et al.
Publicado: (2023)

Price trends of reimbursed oncological drugs in Switzerland in 2005–2019: A descriptive analysis
por: Rachamin, Yael, et al.
Publicado: (2021)

Reporting reimbursement price decisions for onco-hematology drugs in Spain
por: Elvira, David, et al.
Publicado: (2023)

Trends in Shared Decision-Making Studies From 2009 to 2018: A Bibliometric Analysis
por: Lu, Cuncun, et al.
Publicado: (2019)

Time to market for drugs approved in Canada between 2014 and 2018: an observational study
por: Lexchin, Joel
Publicado: (2021)

Spatial Epidemiology of Salmonellosis in Florida, 2009–2018
por: Li, Xiaolong, et al.
Publicado: (2021)

Association Between Residence Status Regularization and Access to Healthcare for Undocumented Migrants in Switzerland: A Panel Study
por: Fakhoury, Julien, et al.
Publicado: (2022)

Drug Utilization and Drug Pricing in the Private Primary Healthcare System in Malaysia: An Employer Price Control Mechanism
por: Zin, Che Suraya, et al.
Publicado: (2020)

The impact of drug shortages on drug prices: evidence from China
por: Hu, Shuchen, et al.
Publicado: (2023)

Performance Comparison of Public Hospitals Between 2014 and 2018 in Different Regions of Guangdong Province, China, Following 2017 Medical Service Price Reforms
por: Weng, Kai-Yuan, et al.
Publicado: (2021)

Estimating the Potential Annual Welfare Impact of Innovative Drugs in Use in Switzerland
por: Pavic, Matea, et al.
Publicado: (2014)

An empirical study of the impact of generic drug competition on drug market prices in China
por: Yina, Chen, et al.
Publicado: (2023)

Sex-specific associations between nine metal mixtures in urine and urine flow rate in US adults: NHANES 2009–2018
por: Zhang, Shuai, et al.
Publicado: (2023)

Trends in the diagnosis of diseases of despair in the United States, 2009–2018: a retrospective cohort study
por: Brignone, Emily, et al.
Publicado: (2020)

Mapping the Research on Health Policy and Services in the Last Decade (2009–2018): A Bibliometric Analysis
por: Zhao, Linyan, et al.
Publicado: (2022)

Patients’ access to drugs with rebates in Switzerland – Empirical analysis and policy implications for drug pricing in Europe
por: Carl, David L, et al.
Publicado: (2021)

Analysing effects of financial support for regional suicide prevention programmes on methods of suicide completion in Japan between 2009 and 2018 using governmental statistical data
por: Hasegawa, Toshiki, et al.
Publicado: (2021)

Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature
por: Ocran Mattila, Phyllis, et al.
Publicado: (2021)

Differential impact of minimum unit pricing on alcohol consumption between Scottish men and women: controlled interrupted time series analysis
por: Rehm, Jürgen, et al.
Publicado: (2022)

Approval of Raxibacumab for the Treatment of Inhalation Anthrax Under the US Food and Drug Administration “Animal Rule”
por: Tsai, Chia-Wei, et al.
Publicado: (2015)

Value assessment of NMPA-approved new cancer drugs for solid cancer in China, 2016–2020
por: Luo, Jing, et al.
Publicado: (2023)

www.coronabambini.ch: Development and usage of an online decision support tool for paediatric COVID-19-testing in Switzerland: a cross-sectional analysis
por: Starvaggi, Carl Alessandro, et al.
Publicado: (2023)

Association of sodium intake with diabetes in adults without hypertension: evidence from the National Health and Nutrition Examination Survey 2009–2018
por: Ming, Li, et al.
Publicado: (2023)

Measuring the macroeconomic determinants of agricultural price volatility: Implications for natural resource commodity prices for green recovery
por: Liu, Hang
Publicado: (2022)

Communicating Healthcare Economic and Pre-approval Information With Healthcare Decision-Makers: Opportunities Following the 21st Century Cures Act and FDA Guidance
por: Niyazov, Alexander, et al.
Publicado: (2018)

Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China: An Interrupted Time Series Study
por: Zhu, Hong, et al.
Publicado: (2022)

Medical service pricing and pharmaceutical supply chain coordination contracts under the zero-markup drug policy
por: Zhou, Nan, et al.
Publicado: (2023)

The role of individual service and team-based service price in the online environment: A view from the price difference
por: Lu, Wei, et al.
Publicado: (2022)

The Association between Depressive Symptoms and Physical Diseases in Switzerland: A Cross-Sectional General Population Study
por: Rodic, Donja, et al.
Publicado: (2015)

Association of Research and Development Investments With Treatment Costs for New Drugs Approved From 2009 to 2018
por: Wouters, Olivier J., et al.
Publicado: (2022)

Trend of unintentional suffocation death for infants under 1 year of age from 2009 to 2018 in Hunan, China: a cross-sectional study
por: Kong, Fanjuan, et al.
Publicado: (2020)

Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance
por: Schneider, Rémi, et al.
Publicado: (2021)

The use of medications approved for alcohol use disorders in Italy
por: Fortinguerra, Filomena, et al.
Publicado: (2023)

Correlation between clinical trial endpoints of marketed cancer drugs and reimbursement decisions in China
por: Ling, Kexin, et al.
Publicado: (2022)

Losing ground at the wrong time: trends in self-reported influenza vaccination uptake in Switzerland, Swiss Health Survey 2007–2017
por: Zürcher, Kathrin, et al.
Publicado: (2021)

Use of tobacco, nicotine and cannabis products among students in Switzerland
por: Affolter, Jana, et al.
Publicado: (2023)

To what degree are review outcomes aligned for new active substances (NASs) between the European Medicines Agency and the US Food and Drug Administration? A comparison based on publicly available information for NASs initially approved in the time period 2014 to 2016
por: Kühler, Thomas Christian, et al.
Publicado: (2019)

Exploring time-varying impact of world pandemic uncertainty on China's commodity prices using TVP-SVAR-SV model
por: Cao, Qiang, et al.
Publicado: (2022)

Association between population prevalence of smoking and incidence of meningococcal disease in Norway, Sweden, Denmark and the Netherlands between 1975 and 2009: a population-based time series analysis
por: Norheim, Gunnstein, et al.
Publicado: (2014)

Outcome of patients with double valve surgery between 2009 and 2018 at University Hospital Basel, Switzerland
por: Egger, Martin L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ip06cmge1g5o0ntbcqffj96840